Actar was founded in 2000 and is a biomedical company who builds the bridge from academic research that further pharmaceutical development needs by identifying, selecting and refining innovative biological targets. Actar substantially increases the value of each target by offering validated and complete licensing opportunities with substantial potential for pharmaceutical development.
|